Effects of osmotic solutes on fibronectin mRNA expression in rat peritoneal mesothelial cells

被引:34
|
作者
Kumano, K
Schiller, B
Hjelle, JT
Moran, J
机构
[1] Kitasato University Hospital, Sagamihara
[2] Rush Presbyterian Medical Center, Chicago, IL
[3] University of Illinois College of Medicine, Peoria, IL
[4] Baxter Healthcare Corporation, McGaw Park, IL
关键词
osmotic agent; glucose; mannitol; fibronectin mRNA; peritoneal mesothelial cells; peritoneal fibrosis;
D O I
10.1159/000170258
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertonic glucose in a peritoneal dialysate may modulate cell metabolism in the peritoneal cavity during continuous ambulatory peritoneal dialysis (CAPD). To examine the effects of high glucose concentration and hyperosmolarity, rat mesothelial cells were cultured for 3 or 6 days in media containing either 5, 25 or 50 mM glucose or 5 mM glucose containing 20 or 45 mM mannitol. Fibronectin gene expression was investigated by Northern blot analysis. By day 6, fibronectin mRNA levels increased compared to 5 mM glucose controls with increasing glucose concentration (25 mM, 193%; 50 mM, 314%); high osmolarity due to mannitol did not increase mRNA levels (20 mM and 45 mM mannitol yielded 75 and 104%, respectively). Thus, hypertonic glucose augments fibronectin gene expression in peritoneal mesothelial cells due to the higher concentrations of glucose and not to hyperosmolarity. This glucose-driven increase in fibronectin expression may contribute to the peritoneal fibrosis in CAPD patients.
引用
收藏
页码:165 / 169
页数:5
相关论文
共 50 条
  • [21] Effect of Ligustrazine on rat peritoneal mesothelial cells treated with lipopolysaccharide
    Zhang, Hui
    Li, Dongxia
    Li, Zhiyong
    Song, Yu
    RENAL FAILURE, 2016, 38 (06) : 961 - 969
  • [22] Effects of New Peritoneal Dialysis Solutions, Pyridoxamine and AT1 Receptor Blocker, on TGF-β1 and VEGF Expression in Rat Peritoneal Mesothelial Cells
    Mizuiri, Sonoo
    Ohashi, Yasushi
    Hemmi, Hiromichi
    Arita, Michitsune
    Yamada, Kanae
    Aoki, Toshiyuki
    Miyagi, Moriatsu
    Sakai, Ken
    Aikawa, Atsushi
    AMERICAN JOURNAL OF NEPHROLOGY, 2009, 30 (03) : 295 - 302
  • [23] Role of Myocardin on the Expression of Fibronectin 1 in Human Pleural Mesothelial Cells
    Sakai, T.
    Choo, Y.
    Ikebe, R.
    Jeffers, A.
    Idell, S.
    Tucker, T. A.
    Ikebe, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [24] FIBRONECTIN ON THE SURFACE OF RAT PERITONEAL MAST-CELLS
    SASAKI, J
    OTSUKA, N
    SUGIYAMA, K
    JOURNAL OF ELECTRON MICROSCOPY, 1981, 30 (03): : 253 - 253
  • [25] Human peritoneal mesothelial cell (HPMC) function in pyruvate buffered peritoneal dialysis solutions (PDF): Effects on mRNA expression and cytokine synthesis
    Topley, N
    Kaur, D
    Mahiout, A
    Williams, JD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0935 - A0935
  • [26] Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of peritoneal dialysis
    Sanusi, AA
    Zweers, MM
    Weening, JJ
    de Waart, DR
    Struijk, DG
    Krediet, RT
    PERITONEAL DIALYSIS INTERNATIONAL, 2001, 21 (05): : 495 - 500
  • [27] Peritoneal dialysis fluids can alter HSP expression in human peritoneal mesothelial cells
    Bender, Thorsten O.
    Boehm, Michael
    Kratochwill, Klaus
    Vargha, Regina
    Riesenhuber, Andrea
    Witowski, Janusz
    Joerres, Achim
    Wieslander, Anders
    Aufricht, Christoph
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (03) : 1046 - 1052
  • [28] The inhibitory effect of PPARγ agonists on the production of CTGF and fibronectin by cultured human peritoneal mesothelial cells
    Sohn, Seung Hyun
    Kim, Seong Eun
    Bae, Hae-Rahn
    Rha, Seo-Hee
    An, Won-Suk
    Jeon, Gun Ung
    Kim, Ki Hyun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 295 - 295
  • [29] Fluvastatin inhibits the expression of fibronectin in human peritoneal mesothelial cells induced by high-glucose peritoneal dialysis solution via SGK1 pathway
    Zhang, Li
    Liu, Jia
    Liu, Yanchun
    Xu, Yaguang
    Zhao, Xiufen
    Qian, Jun
    Sun, Bin
    Xing, Changying
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (03) : 336 - 342
  • [30] ATORVASTATIN REDUCES HIGH GLUCOSE TOXICITY IN RAT PERITONEAL MESOTHELIAL CELLS
    Carrion, Blanca
    Perez-Martinez, Francisco C.
    Monteagudo, Silvia
    Perez-Carrion, Maria D.
    Gomez-Roldan, Carmen
    Cena, Valentin
    Perez-Martinez, Juan
    PERITONEAL DIALYSIS INTERNATIONAL, 2011, 31 (03): : 325 - 331